IP Verse

Wittkopp patent opposition analysis

The comprehensive analysis of Wittkopp opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Wittkopp

Stay updated with the latest patent oppositions filed by Wittkopp

Patent NumberTitleApplicantOpposition DateOpposition Company
EP3435996
Methods Of Treatment Of Cholestatic DiseasesGENFITJan 29, 2026HAMM & WITTKOPP
EP4212152
Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTISJan 29, 2026HETERO LABS
EP4212152
Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTISJan 23, 2026SYNTHON
EP3592732
Manufacture Of A Crystalline Pharmaceutical ProductORIONJan 8, 2026HAMM & WITTKOPP
EP3518975
Formulation For Inhibiting Formation Of 5-Ht 2B Agonists And Methods Of Using SameZOGENIXJan 6, 2026ALFRED E TIEFENBACHER
EP3470400
Crystal Form Of Ozanimod, Crystal Form Of Hydrochloride Thereof, And Preparation Method ThereforCRYSTAL PHARMACEUTICAL SUZHOUDec 19, 2025SYNTHON
EP3570840
Combinations Of Cabozantinib And Atezolizumab To Treat CancerEXELIXISDec 19, 2025STADA ARZNEIMITTEL
EP3756650
Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-DioneAMGEN EUROPEDec 19, 2025HAMM & WITTKOPP
EP3798224
Solid State Forms Of Ixazomib CitrateTEVA PHARMACEUTICALSDec 19, 2025HAMM & WITTKOPP
EP3957789
Gas Diffusion Electrode Substrate, Method For Producing Same, Gas Diffusion Electrode, Membrane-Electrode Assembly, And Solid Polymer Fuel CellTORAY INDUSTRIESDec 16, 2025CARL FREUDENBERG

Top clients of Wittkopp

Top companies who are the clients of Wittkopp

CompanyTotal
HAMM & WITTKOPP107
STADA ARZNEIMITTEL79
ALFRED E TIEFENBACHER49
SYNTHON24
BETAPHARM ARZNEIMITTEL11
POLPHARMA10
WITTKOPP10
ALVOGEN IPCO4
G L PHARMA4
TEVA PHARMACEUTICALS4